Hodgkin disease: Pharmacologic intervention of the CD40-NFκB pathway by a protease inhibitor

Blood

Volumn 96, Issue 8, 2000, Pages 2841-2848

  Annunziata, Christina M ^a   Safiran, Yassamin J ^a   Irving, Steven G ^a   Kasid, Usha N ^a   Cossman, Jeffrey ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPSTATIN; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HODGKIN DISEASE; IMMUNOGLOBULIN GENE; INFLAMMATORY INFILTRATE; PRIORITY JOURNAL; REED STERNBERG CELL; SIGNAL PROCESSING;

EID: 0034667541     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2841.h8002841_2841_2848     Document Type: Article

References (41)

1. Clonality and germinal centre B-cell derivation of Hodgkin/ Reed-Sternberg cells in Hodgkin's disease
2. Reed-Sternberg cell genome expression supports a B-cell lineage
3. The tumor necrosis factor ligand and receptor families
4. Tumor necrosis factor ligand superfamily: Involvement on the pathology of malignant lymphomas
5. CD40/CD40L interactions in normal reactive and malignant lympho-hematopoetic tissues
6. The CD40 antigen and its ligand
7. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
8. Fas ligation induces apoptosis in CD40-activated human B lymphocytes
9. Expression and function of Fas antigen on activated murine B cells
10. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
11. Function and activation of NF-KAPPA B in the immune system
12. TRAF2-mediated activation of NFκB by TNF receptor 2 and CD40
13. TRAF 5, a novel tumor necrosis factor receptor-associated factor family protein mediates CD40 signaling
14. Involvement of CRAF-1, a relative of TRAF, in CD40 signalling
15. Gene expression by single Reed-Sternberg cells: Pathways of apoptosis and activation
16. CD40-mediated signals inhibit the binding of TNF receptor-associated factor 2 to the CD40 cytoplasmic tail
17. Assembly and regulation of the CD40 receptor complex in human B cells
18. TANK, a co-inducer with TRAF2 of TNF-KAPPA B and CD40L-mediated NFκB activation
19. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction
20. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappa B and Jun N-terminal kinase activation
21. MAP3K-related kinase involved in NF-KAPPA B induction by TNF, CD95 and IL-1
22. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NFκB activation
23. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease
24. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells
25. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
26. Cross-linking CD40 on B cells rapidly activates NF-kappa B
27. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines
28. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease
29. Activation of the interleukin-6 gene expression through NF-kappa B transcription factor
30. Reed-Sternberg cell: Survival in a hostile sea
31. Overexpression of I-kappa B alpha without inhibition of NF-kappa B activity and mutations in the I-kappa B alpha gene in Reed-Sternberg cells
32. Defective I-kappa B alpha in Hodgkin cell lines with constitutively active NF-kappa B
33. I-kappa B beta regulates the persistent response in a biphasic activation of NF-kappa B
34. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
35. A cytokine-responsive IκB kinase that activates the transcription facto NF-KAPPA-B
36. Mode of inhibition of acid proteases by pepstatin
37. The selectivity of statine-based inhibitors against various human aspartic proteinases
38. Human B cell precursors proliferate and express CD23 after CD40 ligation
39. High-level nuclear NFκB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
40. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways
41. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation